Data for (Study ST001466)
(Analysis AN002441)Values for each metabolite have been scaled by dividing by the mean across all factors Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this studyMetabolite | F1 | F2 | F3 |
---|---|---|---|
Ace-2_1 | 1.2624 | NA | 0.7901 |
aGlc_1 | 0.7177 | 0.7076 | 1.3815 |
aGlc_2 | 1.0000 | NA | NA |
Ala-3_1 | 1.3271 | 0.5337 | 0.9060 |
Ala-3_2 | 1.2520 | 0.4763 | 0.9226 |
Asp-3a_1 | 1.4128 | 0.6329 | 0.8395 |
Asp-3a_2 | 1.3749 | 0.5535 | 0.9109 |
Asp-3a_3 | 1.5092 | 0.5081 | 0.8216 |
Asp-3a_4 | 1.3879 | 0.5345 | 0.9095 |
Asp-3b_1 | 1.4382 | 0.6008 | 0.8344 |
Asp-3b_2 | 1.3987 | 0.5834 | 0.8760 |
AXP-1^_1 | 1.0694 | 0.5708 | 1.1452 |
AXP-2_1 | 1.5978 | 0.1027 | 0.8508 |
AXP-8_1 | 2.3934 | 0.0618 | 0.0757 |
bGlc_1 | 1.0896 | 0.4755 | 1.1875 |
bGlc_2 | 1.0059 | 0.6061 | 1.1940 |
DSS_1 | 1.0486 | 1.0181 | 0.9424 |
Gln-4_1 | 0.7537 | NA | 1.2463 |
Gln-4_2 | 1.0000 | NA | NA |
Gln+Glu-2_1 | 0.8037 | 0.6746 | 1.3263 |
Gln+Glu-2_2 | 1.8732 | NA | 0.1268 |
Gln+Glu-2_3 | 1.0000 | NA | NA |
Gln+Glu-2_4 | 1.0000 | NA | NA |
Glu-3-a_1 | 0.5002 | 0.9882 | 1.4224 |
Glu-3-a_2 | 1.2675 | NA | 0.5988 |
Glu-3-a_3 | 1.2461 | NA | 0.6309 |
Glu-3-a_4 | 1.1447 | NA | 0.5659 |
Glu-3-a_5 | 1.4010 | NA | 0.1980 |
Glu-3-b_1 | 1.0802 | 0.7391 | 1.0636 |
Glu-3-b_2 | 0.8774 | NA | 1.1838 |
Glu-4_1 | 1.6271 | 0.4842 | 0.7353 |
Gly_1 | 1.2515 | 0.5657 | 1.0076 |
Glycogen_1 | 0.9864 | 0.0460 | 1.2554 |
GSH-8_1 | 1.0000 | NA | NA |
GSH+GSSG-3_1 | 1.6678 | 0.7856 | 0.6422 |
GSH+GSSG-3_2 | 1.0000 | NA | NA |
GSH+GSSG-4_1 | 1.1713 | 0.2451 | 1.1089 |
GSH+GSSG-4_2 | 1.0000 | NA | NA |
GSSG-12_1 | 1.1173 | NA | 0.8241 |
Lac-2_1 | 1.3782 | 0.7745 | 0.7976 |
Lac-2_2 | 1.2289 | 0.4768 | 0.9836 |
Lac-3_1 | 1.2669 | 0.5318 | 0.9672 |
Lac-3_2 | 1.3271 | 0.4256 | 0.9601 |
NAD+-A1^_1 | 1.4528 | NA | 0.5472 |
NAD+-N1^_1 | 1.1647 | 0.5531 | 1.0588 |
Succinate-2,3_1 | 1.3145 | 0.6077 | 0.9341 |
UXP-1^_1 | 1.4029 | 0.2509 | 0.9716 |
Factors:
F1 | Treatment Protocol:allogenic |
F2 | Treatment Protocol:naive |
F3 | Treatment Protocol:syngenic |